Amplification of the KCNMA1 gene was observed in 16% of advanced prostate tumors [2] and an up-regulation of its expression was observed in breast carcinoma [3,4,5], prostate cancer [6], glioblastoma [7], and cervical cancers [8]. This evidence concerns the gene KCNMA1 and breast carcinoma.